August 12, 2009 - Invivo Corp. launches DynaTRIM, a first-of-its-kind fully MR compatible interventional device for Trans-Rectal Interventional MR (TRIM) biopsy of the prostate gland.
This complete clinical MR solution for prostate combines new DynaCAD for Prostate, an advanced clinical visualization system, and new DynaTRIM, a device for the first MR-guided intervention application. The combined solution offers a truly new imaging and intervention option for many patients with elevated and/or rising PSA levels.

Over the past five years, at the following clinical sites - Fox Chase Cancer Center, Philadelphia, Penn., Radboud University of Nijmegen, The Netherlands, University of Chicago, Ill., and Desert Medical Imaging, Indian Wells, Calif. - clinicians have assisted Invivo in the evaluation of this software with its comprehensive set of advanced prostate image visualization tools for performing real-time image analysis and interventional procedure planning.

“DynaCAD for Prostate provides increased operational efficiency enabling the radiologist to rapidly interpret the 3,000 images that constitute a dynamic contrast enhanced prostate MRI,” said John Feller, Chief Medical Officer at Desert Medical Imaging.

The Urologist faces the dilemma of patients with elevated and/or rising PSA levels and negative TRUS-guided biopsy results. The Invivo complete clinical MR prostate solution is designed to offer an alternative to keeping patients in an uncertain state. DynaTRIM reportedly enables the physician to conduct targeted MRI-guided interventions of the prostate gland reducing the number of cores acquired during biopsy. “Especially for patients that have had several sessions of biopsies with negative results; they only need a maximum of 4 MR-guided biopsies with a detection rate of 59 percent,” according to Dr. Inge von Oort, Onocological Urologist, University of Medical Center Nijmegen, the Netherlands.

For more information: www.invivocorp.com


Related Content

News | Breast Biopsy Systems

July 7, 2021 — GE Healthcare announced the installation of Serena Bright in five hospitals and radiology centers around ...

Time July 07, 2021
arrow
News | Breast Imaging

January 4, 2021 — Hologic, Inc. announced it has completed the acquisition of SOMATEX Medical Technologies GmbH, a ...

Time January 04, 2021
arrow
News | Prostate Cancer

According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their lifetime. It’s both the second most common cancer and second most common cause of cancer death in American men. Early detection is critical and can increase a man’s chances of survival.

Time August 20, 2019
arrow
News | Biopsy Systems

Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy device which leverages the real-time tissue characterization capability of its radiofrequency (RF) spectroscopy technology.

Time March 29, 2019
arrow
Technology | Interventional Radiology

The U.S. Food and Drug Administration (FDA) cleared the Ion endoluminal system from Intuitive Surgical Inc. to enable minimally invasive biopsy in the peripheral lung.

Time February 20, 2019
arrow
News | Prostate Cancer

Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two companies work to improve the way prostate cancer is visualized and detected. Cambridge Consultants is applying deep learning to high-resolution micro-ultrasound imaging to identify potential suspicious regions of tissue and inform urologists who may want to consider this additional data in their biopsy protocol. Early results show real promise, according to the companies.

Time February 12, 2019
arrow
News | Breast Biopsy Systems

A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce unnecessary breast biopsies, according to a new study appearing in the journal Radiology

Time January 17, 2019
arrow
Videos | Radiation Oncology

Aadel Chaudhuri, M.D., assistant professor of radiation oncology, Washington University, St. Louis, Mo., explains his ...

Time November 07, 2018
arrow
News | Radiation Oncology

October 30, 2018 — A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to ...

Time October 30, 2018
arrow
Technology | Breast Biopsy Systems

Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system for breast tissue biopsies.

Time October 03, 2018
arrow
Subscribe Now